Hosted on MSN2d
Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%.
Novo Nordisk is working on a new obesity ... past few months as investors fret that demand for weight-loss drugs isn’t as ...
Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide
THURSDAY, Nov. 7, 2024 (HealthDay News) -- The head of the company that makes the diabetes and obesity drugs Ozempic and ...
New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...
Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware
Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...
Novo Nordisk: Be Greedy When Others Are Fearful
Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...
Weight Loss Injections: What You Need to Know, From Costs to Alternatives
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
MedPage Today on MSN2d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss Drugs
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Medscape2d
Oral Semaglutide 25-mg Dose May Provide Most Benefit
SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...
Medscape3h
Semaglutide 2.4 mg Could Cut Medical Costs for Some
A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...
Woman Dies After Using Weight-Loss Drug In U.K.’s First Case
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...
Buy Rating for Novo Nordisk: Strategic Growth and Market Opportunities Amid Supply Challenges
Analyst Michael Nedelcovych from TD Cowen maintained a Buy rating on Novo Nordisk (NVO – Research Report) and keeping the price target at ...
Health.com on MSN2d
Can This Weight Loss Drug Alleviate Knee Pain? Experts Weigh In
A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...